S. Marusicgalesic et al., ALTERED ALLOGENEIC RESPONSE IN NEONATALLY ANTI-MHC CLASS I-TREATED MICE, Scandinavian journal of immunology, 43(3), 1996, pp. 321-328
Neonatal treatment of C3H mice (H-2(k)) with anti-K-k monoclonal antib
odies results in altered cytotoxic responses against allogeneic target
s. After 2-3 weeks of antibody treatment, no difference in the number
of CD4(+)8(-) or CD4(-) 8(+) T cells was observed between the antibody
- and saline-treated mice. However, antibody-treated mice had a signif
icantly reduced cytotoxic response against various allogeneic major hi
stocompatibility complex (MHC) class I-expressing targets. The stronge
st reduction was observed in very young mice (up to 2 weeks of age). A
s the mice got older, the allo MHC-specific responses reached control
levels. No significant changes in T-cell receptor (TCR)-V-region usage
was observed even in young antibody-treated mice. The results suggest
that the reduction in the number of positively selecting elements red
uces alloreactivity and most likely also the diversity of TCR-repertoi
re. However, the reduced alloresponsiveness was not restricted to eith
er allogeneic K- or D-encoded molecules, suggesting that self MHC-D-re
gion encoded molecules can mediate positive selection of T cells able
to react against both K and D region-encoded allogeneic MHC class I mo
lecules.